Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Novartis MenB Vaccine in Healthy Infants
NCT00721396Phase 2Completed
- Sponsor
- Novartis
- Start
- Aug 2008
- Primary completion
- Jul 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 6
01
Overview
A Phase 2 trial of Multicomponent meningococcal B vaccine in Meningococcal B infection, sponsored by Novartis. Started Aug 2008; status: completed.
02
Drugs
Multicomponent meningococcal B vaccine
03
Conditions
Meningococcal B infection
Beyond the preview
Go deeper on NCT00721396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00721396.